A Phase II Trail of Tetrathiomolybdate in Patients With Hormone Refractory Prostate Cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Tetrathiomolybdate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Nov 2005 New trial record.